| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/2010 | WO2010055977A1 Method for screening therapeutic agent for neural diseases using gaba b receptors and p-creb |
| 05/20/2010 | WO2010055974A1 Composition for preventing and treating diabetes and metabolic syndrome disorders containing obovatol and derivatives thereof as active ingredients |
| 05/20/2010 | WO2010055950A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound |
| 05/20/2010 | WO2010055911A1 Biphenylacetamide derivative |
| 05/20/2010 | WO2010055833A1 Composition for inhibiting fgf-5, hair tonic, and composition for external use on livestock |
| 05/20/2010 | WO2010055526A1 A novel polymorph of emtricitabine and a process for preparing of the same |
| 05/20/2010 | WO2010055513A1 Methods of diagnosing hypersensitivity to a female reproductive hormone and treating medical conditions associated with same |
| 05/20/2010 | WO2010055474A2 Antimicrobial compounds and compositions |
| 05/20/2010 | WO2010055461A1 Method of treating sleep disorders using eplivanserin |
| 05/20/2010 | WO2010055419A2 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis |
| 05/20/2010 | WO2010055371A1 Medicament for inhibiting the synthesis of leukotrienes |
| 05/20/2010 | WO2010055348A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials |
| 05/20/2010 | WO2010055340A1 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer |
| 05/20/2010 | WO2010055304A2 Pharmaceutical compounds |
| 05/20/2010 | WO2010055268A1 Novel method for preparing granulates of active principles, and granulates obtained thereof |
| 05/20/2010 | WO2010055267A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 05/20/2010 | WO2010055260A1 Novel composition based on gamma-hydroxybutyric acid |
| 05/20/2010 | WO2010055254A1 Histidinol dehydrogenase inhibitors, and use thereof as medicaments |
| 05/20/2010 | WO2010055170A1 Pyrimidinium derivatives for use in the treatment or prevention of diabetes |
| 05/20/2010 | WO2010055164A2 Novel inhibitors of flavivirus replication |
| 05/20/2010 | WO2010055148A2 Dosage of oligonucleotides suitable for the treatment of tumors |
| 05/20/2010 | WO2010055139A1 Process for manufacturing substituted 3-pyridylmethyl ammonium bromides |
| 05/20/2010 | WO2010055133A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055132A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055131A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055130A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055129A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055128A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055127A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055126A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055125A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055124A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | WO2010055122A1 Octenidine composition |
| 05/20/2010 | WO2010055119A2 Pharmaceutical composition comprising pimobendan |
| 05/20/2010 | WO2010055117A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth |
| 05/20/2010 | WO2010055083A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors |
| 05/20/2010 | WO2010055082A2 New crystal form of sunitinib malate |
| 05/20/2010 | WO2010055081A1 Use of leukotriene inhibitors for treating lung diseases in prematurely born infants |
| 05/20/2010 | WO2010055072A2 Treating cancer by modulating a mnk |
| 05/20/2010 | WO2010055028A2 Organic compounds |
| 05/20/2010 | WO2010055023A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 05/20/2010 | WO2010055022A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 05/20/2010 | WO2010055021A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
| 05/20/2010 | WO2010055006A1 Naphthylacetic acids used as crth2 antagonists or partial agonists |
| 05/20/2010 | WO2010055005A1 Naphthylacetic acids |
| 05/20/2010 | WO2010055004A1 Naphthylacetic acids |
| 05/20/2010 | WO2010054978A1 Compound useful for treating cellulite |
| 05/20/2010 | WO2010054968A1 Quinazoline derivatives as nk3 receptor antagonists |
| 05/20/2010 | WO2010054961A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes |
| 05/20/2010 | WO2010054858A2 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens |
| 05/20/2010 | WO2010054833A1 Intermediate and oral administrative formats containing lenalidomide |
| 05/20/2010 | WO2010054826A1 Antisense compositions and methods of making and using same |
| 05/20/2010 | WO2010054818A1 Nmp-containing extract, a method of its production and uses thereof |
| 05/20/2010 | WO2010054764A1 Heteroaromatic compounds for use as hif inhibitors |
| 05/20/2010 | WO2010054763A1 Heterocyclically substituted aryl compounds as hif inhibitors |
| 05/20/2010 | WO2010054762A1 Aminoalkyl-substituted compounds as hif inhibitors |
| 05/20/2010 | WO2010054758A1 Synergistic pharmaceutical combination comprising an estrogen receptor antagonist and a progestin |
| 05/20/2010 | WO2010054606A2 Triterpenoid 2-deoxy glycosides, method of preparation thereof and use thereof as medicaments |
| 05/20/2010 | WO2010054575A1 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof |
| 05/20/2010 | WO2010054565A1 The water-soluble prodrug of (r)-(-)-bicalutamide, its preparation method and uses thereof |
| 05/20/2010 | WO2010054533A1 Cyproheptadine hydrochloride cream and preparation method thereof |
| 05/20/2010 | WO2010054528A1 Quinazoline compounds |
| 05/20/2010 | WO2010054520A1 Pharmaceutical composition for purifing vein and preparation method thereof |
| 05/20/2010 | WO2010054512A1 Two types of crystalline of pinocembrin: α and β, their preparation and their use for manufacture of pharmaceutical compositions |
| 05/20/2010 | WO2010054507A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives |
| 05/20/2010 | WO2010054485A1 Organic nutrient salts, methods of preparation and uses |
| 05/20/2010 | WO2010054470A1 Pumpkin and rose hips weight loss composition |
| 05/20/2010 | WO2010054469A1 Appetite suppressing weight management composition |
| 05/20/2010 | WO2010054452A1 New compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method |
| 05/20/2010 | WO2010054438A1 Aryl di-substituted propenone compounds |
| 05/20/2010 | WO2010036631A3 Sulfonyl compounds which selectively modulate the cb2 receptor |
| 05/20/2010 | WO2010036630A3 Sulfonyl compounds which selectively modulate the cb2 receptor |
| 05/20/2010 | WO2010036407A3 Antiviral nucleoside analogs |
| 05/20/2010 | WO2010033167A3 Anti-thrombin aptamer formulations and methods for use |
| 05/20/2010 | WO2010030704A3 Antibacterial aminoglycoside analogs |
| 05/20/2010 | WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof |
| 05/20/2010 | WO2010022017A3 Method and composition for enhancing hematopoietic stem cell mobilization |
| 05/20/2010 | WO2010020647A3 New method for identifying compounds useful for treating and/or preventing disease-associated with bone loss |
| 05/20/2010 | WO2010019489A3 Method for making terpene derivatives |
| 05/20/2010 | WO2010018217A3 Purin derivatives for use in the treatment of fab-related diseases |
| 05/20/2010 | WO2010017550A3 Lipid compounds for supression of tumorigenesis |
| 05/20/2010 | WO2010017541A3 Compositions and methods for treatment of neurodegenerative disease |
| 05/20/2010 | WO2010017094A3 CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING |
| 05/20/2010 | WO2010014933A3 Psma-binding agents and uses thereof |
| 05/20/2010 | WO2010013078A8 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 05/20/2010 | WO2010011857A3 Parenteral administration of a glucosamine |
| 05/20/2010 | WO2010006162A3 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 05/20/2010 | WO2010005836A3 Use of rifalazil to treat colonic disorders |
| 05/20/2010 | WO2009152500A4 Methods and compositions for mediating gene silencing |
| 05/20/2010 | WO2009140309A3 Boron-containing small molecules |
| 05/20/2010 | WO2009125117A3 Dermatological composition that can be used in particular for the care and prevention of eschars |
| 05/20/2010 | WO2009124971A3 Novel compositions and their use |
| 05/20/2010 | WO2009121623A3 Compounds for treating muscular dystrophy |
| 05/20/2010 | WO2009117151A3 Vitamin e derivatives and their uses |
| 05/20/2010 | WO2009102433A3 Compounds with mdr1-inverse activity |
| 05/20/2010 | WO2009091576A3 Parenteral formulations of dopamine agonists |
| 05/20/2010 | WO2008121634A3 Nucleoside phosphoramidate prodrugs |
| 05/20/2010 | US20100125150 salt formation to form N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; crystal forms |
| 05/20/2010 | US20100125131 Gene Encoding A Guanine Nucleotide Exchange Factor And The Gene Product Thereof |
| 05/20/2010 | US20100125103 Composition for the treatment of diabetes and metabolic syndrome containing obovatol and its synthesized derivatives |